STRATEGIC MARKETING INNOVATIONS

Lobbying for CIVICA RX · Pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Utah · House · Senate · $10,000.00 income · posted Jul 17, 2025

Lobbying activity 2

Health Issues

Onshoring domestic pharmaceutical industrial base

Defense

Onshoring domestic pharmaceutical industrial base

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.